Skip to main content
Equibles
ACOG logo

ACOG · Alpha Cognition Inc. · Metrics

Track ACOG — free

Use ACOG with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ACOG.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$8.90 +0.00 (+0.00%) At close · Sep 11
Rebalance outlook locked
Market Cap
$192.30M
Shares
21.78M

ACOG metrics

64 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$8.90
Market cap
$192.30M

Price action

20 metrics
Price change (1W)
-3.4%
Price change (30D)
+3.1%
Price change (3M)
+47.4%
Price change (6M)
+52.1%
Price change (YTD)
+36.9%
Price change (1Y)
-7.8%
Trailing year
Price change (5Y)
—
52-week high
$9.80
52-week low
$4.50
Change from 52-week high
-9.2%
Change from 52-week low
+97.8%
Annualized volatility
66.4%
Annualized volatility (3M)
56.8%
Beta
1.1
RSI (14D)
47.3
Price vs SMA 50
+1.8%
Price vs SMA 200
+33.7%
Avg volume (3M)
107,030
Relative volume
0.8
Average dollar volume
$925,715

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
21.78M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
12.6×
reciprocal yield 7.9%
P / book
3.6
reciprocal yield 27.5%
FCF yield
-16.2%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-10.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-03-31

Profitability

9 metrics
Gross margin
94.1%
Operating margin
-174.7%
Trailing 12 months
Net margin
-137.7%
Gross profit (TTM)
—
Operating profit (TTM)
−$26.66M
Net income (TTM)
−$21.01M
Trailing 12 months
Diluted EPS (TTM)
$-0.97
FCF margin
-204.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$2.88

Growth

11 metrics
Revenue growth YoY
+267.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$15.26M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+35.9%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-39.7%
Return on assets
-32.6%
Debt / equity
—
Current ratio
9.0
EBITDA (TTM)
−$26.49M
Free cash flow (TTM)
−$31.18M
Quick ratio
8.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$41.38M
Latest balance sheet
Cash & equivalents
$41.38M
Total assets
$64.52M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$30.85M
Capital expenditures (TTM)
$321,796
R&D (TTM)
$4.17M
SG&A (TTM)
$36.20M
Stock compensation (TTM)
$5.26M
R&D / revenue
27.3%
Stock compensation / revenue
34.5%

Ownership (13F)

3 metrics
13F filers
25
13F filer change QoQ
0
Institutional ownership
48.1%

Short interest

3 metrics
Short interest
1.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
38 / 100

Insider activity

2 metrics
Net insider buying (90D)
$3.09M
Insider-sentiment score
95 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1655923 CUSIP 02074J501 13F (30d) 19 filings 19 filers Visit website Investor relations